The Association of Body Mass Index with COVID-19 Complications and Survival Rate at a Tertiary Hospital

A high body mass index (BMI) is a known risk factor for coronavirus infection in hospitalized patients. Our study examined the association between BMI and complications and the survival rate among COVID-19 patients. This retrospective analysis used data from a tertiary hospital in the Eastern Region of Saudi Arabia during two waves of the COVID-19 pandemic. The study included 600 participants, with the majority being between 41 and 60 years old (41.3%) and men comprising 63.5% of the sample. Approximately 42.5% of patients were obese, and 31.3% were overweight. The results showed that BMI was significantly linked to respiratory diseases (p = 0.013); end-stage renal disease (p = 0.021); and cardiovascular disease (p = 0.003) but not diabetes mellitus (p = 0.064). Death occurred in 10.8% of patients; 33.8% were admitted to the ICU; 13.8% needed mechanical ventilation; and 60.7% had lung infiltration. Obese patients with oxygen saturation levels below 93% were 2.45 times more likely to require mechanical ventilation than those in the normal-weight group. Overweight and obese patients were also more likely to require mechanical ventilation than normal-weight patients, with odds ratios of 3.66 and 2.81, respectively. The BMI categorized was not associated with survival rate in COVID-19-hospitalized patients using Kaplan-Meier survival plots (p = 0.061). However, the BMI categorized was associated with survival rate in COVID-19 ICU patients (p < 0.001). In addition, the overweight showed a statistically significant higher hazard ratio of 2.22 (p = 0.01) compared to normal-weight patients using a Cox regression model. A high BMI was identified as an independent risk factor for reduced oxygen saturation (<93%), the need for mechanical ventilation, lung infiltration, mortality, and longer ICU stays in COVID-19 patients.

[1]  M. Zangeneh,et al.  Survival analysis based on body mass index in patients with Covid-19 admitted to the intensive care unit of Amir Al-Momenin Hospital in Arak – 2021 , 2022, Obesity Medicine.

[2]  O. Cronie,et al.  BMI, sex and outcomes in hospitalised patients in western Sweden during the COVID-19 pandemic , 2022, Scientific Reports.

[3]  M. Al-Hariri,et al.  The impact of obesity on hospitalized patients with COVID-19 infection in the Eastern Province of Saudi Arabia , 2022, Journal of Medicine and Life.

[4]  C. Rylander,et al.  Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort study , 2021, PloS one.

[5]  Hyunggoo Kang,et al.  The effect of BMI on COVID-19 outcomes among older patients in South Korea: a nationwide retrospective cohort study* , 2021, Annals of medicine.

[6]  A. Sheikh,et al.  Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study , 2020, BMJ.

[7]  Yan-Mei Huang,et al.  Obesity in patients with COVID-19: a systematic review and meta-analysis , 2020, Metabolism.

[8]  H. Alwafi,et al.  Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: An Ecological Study , 2020, Frontiers in Public Health.

[9]  B. Popkin,et al.  Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[10]  K. Khunti,et al.  Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study , 2020, The Lancet Diabetes & Endocrinology.

[11]  C. Pedone,et al.  Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19 , 2020, Diabetes Care.

[12]  H. Rusinek,et al.  Visceral adipose tissue in patients with COVID-19: risk stratification for severity , 2020, Abdominal Radiology.

[13]  I. Pavord,et al.  Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people , 2020, Heart.

[14]  L. Strigari,et al.  Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19 , 2020, Metabolism.

[15]  P. Hegyi,et al.  Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[16]  F. C. Stanford,et al.  Outcomes of COVID-19: disparities in obesity and by ethnicity/race , 2020, International Journal of Obesity.

[17]  K. Bhaskaran,et al.  OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.

[18]  S. Barquera,et al.  The Association of Obesity, Type 2 Diabetes, and Hypertension with Severe Coronavirus Disease 2019 on Admission Among Mexican Patients , 2020, Obesity.

[19]  J. Hewitt,et al.  The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study , 2020, The Lancet Public Health.

[20]  S. O’Rahilly,et al.  When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? , 2020, Med.

[21]  J. Pell,et al.  BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[22]  Feng Gao,et al.  Obesity Is a Risk Factor for Greater COVID-19 Severity , 2020, Diabetes Care.

[23]  J. Sterne,et al.  Collider bias undermines our understanding of COVID-19 disease risk and severity , 2020, Nature Communications.

[24]  R. Carmona,et al.  Failing Another National Stress Test on Health Disparities. , 2020, JAMA.

[25]  W. Dietz,et al.  Obesity and its Implications for COVID‐19 Mortality , 2020, Obesity.

[26]  Lanjuan Li,et al.  Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19) , 2020, Journal of internal medicine.

[27]  M. He,et al.  [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV]. , 2020, Zhonghua xin xue guan bing za zhi.

[28]  A. Pesenti,et al.  Pathophysiology and Management of Acute Respiratory Distress Syndrome in Obese Patients , 2019, Seminars in Respiratory and Critical Care Medicine.

[29]  D. van der A,et al.  The Association Between BMI and Different Frailty Domains: A U-Shaped Curve? , 2018, The journal of nutrition, health & aging.

[30]  He Yu,et al.  Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis , 2017, Critical Care.

[31]  S. Lemeshow,et al.  Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury* , 2006, Critical Care Medicine.

[32]  A. Aljahdali,et al.  The prevalence of obesity in hospitalized COVID-19 patients at King Abdullah Medical City, Makkah, Saudi Arabia , 2021, International Journal of Medicine in Developing Countries.